Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

144 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Mutations affecting G-protein subunit α11 in hypercalcemia and hypocalcemia.
Nesbit MA, Hannan FM, Howles SA, Babinsky VN, Head RA, Cranston T, Rust N, Hobbs MR, Heath H 3rd, Thakker RV. Nesbit MA, et al. Among authors: heath h 3rd. N Engl J Med. 2013 Jun 27;368(26):2476-2486. doi: 10.1056/NEJMoa1300253. N Engl J Med. 2013. PMID: 23802516 Free PMC article.
Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy.
Parsons A, Merritt D, Rosen A, Heath H 3rd, Siddhanti S, Plouffe L Jr; Study Groups on the Effects of Raloxifene HCI With Low-Dose Premarin Vaginal Cream. Parsons A, et al. Among authors: heath h 3rd. Obstet Gynecol. 2003 Feb;101(2):346-52. doi: 10.1016/s0029-7844(02)02726-6. Obstet Gynecol. 2003. PMID: 12576260 Clinical Trial.
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome.
Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders EM, Kennedy AM, Chen JD, Agarwal SK, Sood R, Jones MP, Moses TY, Haven C, Petillo D, Leotlela PD, Harding B, Cameron D, Pannett AA, Höög A, Heath H 3rd, James-Newton LA, Robinson B, Zarbo RJ, Cavaco BM, Wassif W, Perrier ND, Rosen IB, Kristoffersson U, Turnpenny PD, Farnebo LO, Besser GM, Jackson CE, Morreau H, Trent JM, Thakker RV, Marx SJ, Teh BT, Larsson C, Hobbs MR. Carpten JD, et al. Among authors: heath h 3rd. Nat Genet. 2002 Dec;32(4):676-80. doi: 10.1038/ng1048. Epub 2002 Nov 18. Nat Genet. 2002. PMID: 12434154
Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy.
Martin MB, Grimley JS, Lewis JC, Heath HT 3rd, Bailey BN, Kendrick H, Yardley V, Caldera A, Lira R, Urbina JA, Moreno SN, Docampo R, Croft SL, Oldfield E. Martin MB, et al. Among authors: heath ht 3rd. J Med Chem. 2001 Mar 15;44(6):909-16. doi: 10.1021/jm0002578. J Med Chem. 2001. PMID: 11300872
Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials.
Johnston CC Jr, Bjarnason NH, Cohen FJ, Shah A, Lindsay R, Mitlak BH, Huster W, Draper MW, Harper KD, Heath H 3rd, Gennari C, Christiansen C, Arnaud CD, Delmas PD. Johnston CC Jr, et al. Among authors: heath h 3rd. Arch Intern Med. 2000 Dec 11-25;160(22):3444-50. doi: 10.1001/archinte.160.22.3444. Arch Intern Med. 2000. PMID: 11112238 Clinical Trial.
Raloxifene therapy.
Heath H 3rd, Cox DA, Plouffe L Jr. Heath H 3rd, et al. J Am Geriatr Soc. 2000 Sep;48(9):1170-2. doi: 10.1111/j.1532-5415.2000.tb04801.x. J Am Geriatr Soc. 2000. PMID: 10983924 No abstract available.
Update in endocrinology.
Heath H 3rd, Mitlak B, Anderson P. Heath H 3rd, et al. Ann Intern Med. 1999 Aug 17;131(4):309. doi: 10.7326/0003-4819-131-4-199908170-00012. Ann Intern Med. 1999. PMID: 10454953 No abstract available.
144 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page